Latest news
SAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 13:32:43 GMTSAB Biotherapeutics, Inc. Q2 2026: Net loss $(22.5M), EPS $(0.28) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 12:01:01 GMTSAB Biotherapeutics, Inc. Financial Disclosures & SEC Filings - TradingViewTradingView · Thu, 06 Aug 2026 01:11:50 GMT